Per injection site, approximately 4 × 106 cells were suspended in 200 μl of the above medium containing 50% Matrigel (BD Biosciences),56 followed by subcutaneous injection into the dorsal flank of two NOD/SCID mice per iPSC line.
Two different training methods (10-fold cross validation and training/testing) were utilized to obtain two different network architectures, while a Genetic algorithm was utilized to obtain optimal concentrations of the above medium components.
Cells were grown overnight (17 h) in the above medium at 30°C to an OD600 of 0.6.
Then, 2×105 PBMC in the above medium were added in a total volume of 200 µl, in the presence or absence of 10 µg/ml of relevant peptide, and incubated for 40 h at 37°C.
Cells were grown in the above medium and competent cells were prepared similar to E. coli MOS Blue cells with the variation that washing and suspension of the cells were done in 10% glycerol with 0.1% Tween.
Knockdown cells were cultured in the above medium with an addition of 4 μg/ml puromycin.
J.Vav1 cells were cultured in the above medium supplemented with 500 μg/ml G418 (Invitrogen).
Sense and antisense cells were maintained in the above medium supplemented with Geneticin (1 mg/mL G418).
Targeted 38C-3 cells were maintained in the above medium supplemented with 10 μM mycophenolic acid (MPA) (Sigma).
After 3 5 days, cells form clusters/neurospheres of hNPCs, and are further maintained in the above medium until differentiation.
Amplified subclones were selected and maintained in the above medium supplemented with 10 μM MPA and 10 μM mizoribine (Sigma).
